Added to YB: 2024-03-08
Pitch date: 2024-03-07
BHC [neutral]
Bausch Health Companies Inc.
-27.17%
current return
Author Info
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company.
Market Cap
$2.6B
Pitch Price
$9.35
Price Target
12.99 (+89%)
Dividend
N/A
EV/EBITDA
5.61
P/E
-2.35
EV/Sales
2.07
Sector
Pharmaceuticals
Category
value
Show full summary:
Fundamentals: Bausch's Terrible Balance Sheet
BHC: Trades at 2.4x 2024 EPS despite double-digit growth, but heavy debt load (~6x market cap) and patent cliff risk justify low multiple. Credit markets imply 40%+ bankruptcy risk by 2027. $4.9B BLCO stake spin-off could drive 40% upside but currently paused due to lawsuit.
Read full article (9 min)